Suchergebnisse - "Morton, Jennifer P"

The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration von Ritschka, Birgit, Storer, Mekayla, Mas, Alba, Heinzmann, Florian, Ortells, Mari Carmen, Morton, Jennifer P, Sansom, Owen J, Zender, Lars, Keyes, William M

“… Senescence is a form of cell cycle arrest induced by stress such as DNA damage and oncogenes. However, while arrested, senescent cells secrete a variety of …”
Weitere Angaben

Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer von Vennin, Claire, Murphy, Kendelle J, Morton, Jennifer P, Cox, Thomas R, Pajic, Marina, Timpson, Paul

“… Pancreatic cancer is accompanied with a fibrotic reaction that alters interactions between tumor cells and the stroma to promote tumor progression …”
Weitere Angaben

Substrate Rigidity Controls Activation and Durotaxis in Pancreatic Stellate Cells von Lachowski, Dariusz, Cortes, Ernesto, Pink, Daniel, Chronopoulos, Antonios, Karim, Saadia A., P. Morton, Jennifer, del Río Hernández, Armando E.

“… Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive malignancy characterised by the presence of extensive desmoplasia, thought to be responsible for the …”
Volltext

Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models von Heinrich, Marcel A., Mostafa, Ahmed M.R.H., Morton, Jennifer P., Hawinkels, Lukas J.A.C., Prakash, Jai

“… [Display omitted] Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with an overall survival rate of less than 7–8%, …”
Volltext

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer von Halbrook, Christopher J, Pontious, Corbin, Kovalenko, Ilya, Lapienyte, Laura, Dreyer, Stephan, Lee, Ho-Joon, Thurston, Galloway, Zhang, Yaqing, Lazarus, Jenny, Sajjakulnukit, Peter, Hong, Hanna S, Kremer, Daniel M, Nelson, Barbara S, Kemp, Samantha, Zhang, Li, Chang, David, Biankin, Andrew, Shi, Jiaqi, Frankel, Timothy L, Crawford, Howard C, Morton, Jennifer P, Pasca di Magliano, Marina, Lyssiotis, Costas A

“… Pancreatic ductal adenocarcinoma (PDA) is characterized by abundant infiltration of tumor-associated macrophages (TAMs). TAMs have been reported to drive …”
Weitere Angaben

The preclinical gap in pancreatic cancer and radiotherapy von Tesson, Mathias, Morton, Jennifer P.

“… Pancreatic ductal adenocarcinoma is an aggressive malignancy with limited treatment options. Chemotherapy offers little benefit and, although there is some …”
Volltext

A complex secretory program orchestrated by the inflammasome controls paracrine senescence von Acosta, Juan Carlos, Banito, Ana, Wuestefeld, Torsten, Georgilis, Athena, Janich, Peggy, Morton, Jennifer P., Athineos, Dimitris, Kang, Tae-Won, Lasitschka, Felix, Andrulis, Mindaugas, Pascual, Gloria, Morris, Kelly J., Khan, Sadaf, Jin, Hong, Dharmalingam, Gopuraja, Snijders, Ambrosius P., Carroll, Thomas, Capper, David, Pritchard, Catrin, Inman, Gareth J., Longerich, Thomas, Sansom, Owen J., Benitah, Salvador Aznar, Zender, Lars, Gil, Jesús

“… Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the …”
Volltext

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma von Steele, Colin W, Karim, Saadia A, Leach, Joshua D G, Bailey, Peter, Upstill-Goddard, Rosanna, Rishi, Loveena, Foth, Mona, Bryson, Sheila, McDaid, Karen, Wilson, Zena, Eberlein, Catherine, Candido, Juliana B, Clarke, Mairi, Nixon, Colin, Connelly, John, Jamieson, Nigel, Carter, C Ross, Balkwill, Frances, Chang, David K, Evans, T R Jeffry, Strathdee, Douglas, Biankin, Andrew V, Nibbs, Robert J B, Barry, Simon T, Sansom, Owen J, Morton, Jennifer P

“… CXCR2 has been suggested to have both tumor-promoting and tumor-suppressive properties. Here we show that CXCR2 signaling is upregulated in human pancreatic …”
Weitere Angaben

CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer von Pereira, Brooke A, Vennin, Claire, Papanicolaou, Michael, Chambers, Cecilia R, Herrmann, David, Morton, Jennifer P, Cox, Thomas R, Timpson, Paul

“… Cancer-associated fibroblasts (CAFs) are one of the most significant components in the tumour microenvironment (TME), where they can perform several …”
Weitere Angaben

A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression von Auciello, Francesca R, Bulusu, Vinay, Oon, Chet, Tait-Mulder, Jacqueline, Berry, Mark, Bhattacharyya, Sohinee, Tumanov, Sergey, Allen-Petersen, Brittany L, Link, Jason, Kendsersky, Nicholas D, Vringer, Esmee, Schug, Michelle, Novo, David, Hwang, Rosa F, Evans, Ronald M, Nixon, Colin, Dorrell, Craig, Morton, Jennifer P, Norman, Jim C, Sears, Rosalie C, Kamphorst, Jurre J, Sherman, Mara H

“… Pancreatic ductal adenocarcinoma (PDAC) develops a pronounced stromal response reflecting an aberrant wound-healing process. This stromal reaction features …”
Weitere Angaben

Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade von Nielsen, Sebastian R., Strøbech, Jan E., Horton, Edward R., Jackstadt, Rene, Laitala, Anu, Bravo, Marina C., Maltese, Giorgia, Jensen, Adina R. D., Reuten, Raphael, Rafaeva, Maria, Karim, Saadia A., Hwang, Chang-Il, Arnes, Luis, Tuveson, David A., Sansom, Owen J., Morton, Jennifer P., Erler, Janine T.

“… Pancreatic ductal adenocarcinoma (PDAC) patients have a 5-year survival rate of only 8% largely due to late diagnosis and insufficient therapeutic options …”
Volltext

Neutrophils: Homing in on the myeloid mechanisms of metastasis von Leach, Joshua, Morton, Jennifer P., Sansom, Owen J.

“… •Neutrophils play important roles throughout the metastatic process.•Tumour progression and invasion are influenced by infiltrating neutrophils.•Signalling …”
Volltext

Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses von Blagih, Julianna, Zani, Fabio, Chakravarty, Probir, Hennequart, Marc, Pilley, Steven, Hobor, Sebastijan, Hock, Andreas K., Walton, Josephine B., Morton, Jennifer P., Gronroos, Eva, Mason, Susan, Yang, Ming, McNeish, Iain, Swanton, Charles, Blyth, Karen, Vousden, Karen H.

“… Loss of p53 function contributes to the development of many cancers. While cell-autonomous consequences of p53 mutation have been studied extensively, the role …”
Volltext

Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer von Raymant, Meirion, Astuti, Yuliana, Alvaro-Espinosa, Laura, Green, Daniel, Quaranta, Valeria, Bellomo, Gaia, Glenn, Mark, Chandran-Gorner, Vatshala, Palmer, Daniel H., Halloran, Christopher, Ghaneh, Paula, Henderson, Neil C., Morton, Jennifer P., Valiente, Manuel, Mielgo, Ainhoa, Schmid, Michael C.

“… Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease for which better therapies are urgently needed. Fibroblasts and macrophages are …”
Volltext

EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas von Hill, William, Zaragkoulias, Andreas, Salvador-Barbero, Beatriz, Parfitt, Geraint J, Alatsatianos, Markella, Padilha, Ana, Porazinski, Sean, Woolley, Thomas E, Morton, Jennifer P, Sansom, Owen J, Hogan, Catherine

“… As we age, our tissues are repeatedly challenged by mutational insult, yet cancer occurrence is a relatively rare event. Cells carrying cancer-causing genetic …”
Weitere Angaben

Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression von Dozynkiewicz, Marta A, Jamieson, Nigel B, Macpherson, Iain, Grindlay, Joan, van den Berghe, Peter V E, von Thun, Anne, Morton, Jennifer P, Gourley, Charlie, Timpson, Paul, Nixon, Colin, McKay, Colin J, Carter, Ross, Strachan, David, Anderson, Kurt, Sansom, Owen J, Caswell, Patrick T, Norman, Jim C

“… Here we show that Rab25 permits the sorting of ligand-occupied, active-conformation α5β1 integrin to late endosomes/lysosomes. Photoactivation and biochemical …”
Weitere Angaben

Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma von Muthalagu, Nathiya, Monteverde, Tiziana, Raffo-Iraolagoitia, Ximena, Wiesheu, Robert, Whyte, Declan, Hedley, Ann, Laing, Sarah, Kruspig, Björn, Upstill-Goddard, Rosanna, Shaw, Robin, Neidler, Sarah, Rink, Curtis, Karim, Saadia A, Gyuraszova, Katarina, Nixon, Colin, Clark, William, Biankin, Andrew V, Carlin, Leo M, Coffelt, Seth B, Sansom, Owen J, Morton, Jennifer P, Murphy, Daniel J

“… MYC is implicated in the development and progression of pancreatic cancer, yet the precise level of MYC deregulation required to contribute to tumor …”
Weitere Angaben

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype von Candido, Juliana B., Morton, Jennifer P., Bailey, Peter, Campbell, Andrew D., Karim, Saadia A., Jamieson, Thomas, Lapienyte, Laura, Gopinathan, Aarthi, Clark, William, McGhee, Ewan J., Wang, Jun, Escorcio-Correia, Monica, Zollinger, Raphael, Roshani, Rozita, Drew, Lisa, Rishi, Loveena, Arkell, Rebecca, Evans, T.R. Jeffry, Nixon, Colin, Jodrell, Duncan I., Wilkinson, Robert W., Biankin, Andrew V., Barry, Simon T., Balkwill, Frances R., Sansom, Owen J.

“… Pancreatic ductal adenocarcinoma (PDAC) is resistant to most therapies including single-agent immunotherapy and has a dense desmoplastic stroma, and most …”
Volltext

Increased formate overflow is a hallmark of oxidative cancer von Meiser, Johannes, Schuster, Anne, Pietzke, Matthias, Vande Voorde, Johan, Athineos, Dimitris, Oizel, Kristell, Burgos-Barragan, Guillermo, Wit, Niek, Dhayade, Sandeep, Morton, Jennifer P., Dornier, Emmanuel, Sumpton, David, Mackay, Gillian M., Blyth, Karen, Patel, Ketan J., Niclou, Simone P., Vazquez, Alexei

“… Formate overflow coupled to mitochondrial oxidative metabolism\ has been observed in cancer cell lines, but whether that takes place in the tumor …”
Volltext

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer von Morton, Jennifer P, Timpson, Paul, Karim, Saadia A, Ridgway, Rachel A, Athineos, Dimitris, Doyle, Brendan, Jamieson, Nigel B, Oien, Karin A, Lowy, Andrew M, Brunton, Valerie G, Frame, Margaret C, Evans, T R Jeffry, Sansom, Owen J

“… TP53 mutation occurs in 50-75% of human pancreatic ductal adenocarcinomas (PDAC) following an initiating activating mutation in the KRAS gene. These p53 …”
Weitere Angaben